News for 'aging research'

Younger more affected by Covid as they're going out: ICMR

Younger more affected by Covid as they're going out: ICMR

Rediff.com11 May 2021

In response to a question on whether younger population were getting more affected, Indian Council of Medical Research Director General Dr Balram Bhargava said the comparison of data during the first and the second wave of COVID-19 has shown that there is not much age difference.

No evidence Omicron has lower severity than Delta: Study

No evidence Omicron has lower severity than Delta: Study

Rediff.com20 Dec 2021

The study estimates that the risk of reinfection with the Omicron variant is 5.4 times greater than that of the Delta variant.

RSS outfit starts 'garbh sanskar' to teach cultural values in womb

RSS outfit starts 'garbh sanskar' to teach cultural values in womb

Rediff.com6 Mar 2023

Samvardhinee Nyas, an affiliate of the Rashtriya Swayamsevak Sangh, has started a campaign titled 'Garbha Sanskar' for pregnant women to teach babies culture and values in the womb, its national organising secretary Madhuri Marathe said on Monday.

First cases of B.A. sub-lineage of Omicron found in Maharashtra

First cases of B.A. sub-lineage of Omicron found in Maharashtra

Rediff.com28 May 2022

For the first time in Maharashtra, four patients of B.A.4 sub-lineage and three cases of B.A.5 sub-lineage of the Omicron variant of coronavirus have been found, the state health department said on Saturday.

Global Hunger Index doesn't really measure hunger: Health ministry

Global Hunger Index doesn't really measure hunger: Health ministry

Rediff.com18 Oct 2022

The Global Hunger Index exaggerates the measure of hunger, lacks statistical vigour and has problems on multiple counts, Union Health Ministry sources said.

India's rich club grows to 1,103; Zepto's Kaivalya youngest in Hurun list

India's rich club grows to 1,103; Zepto's Kaivalya youngest in Hurun list

Rediff.com22 Sep 2022

One hundred and forty nine new individuals joined the rich list club of 1,103 Indians across 122 cities who cumulatively accumulated a wealth of Rs 100 trillion. Bengaluru -based Kaivalya Vohra, 19, of grocery delivery application Zepto is the youngest self-made and the youngest rich individual, according to IIFL Wealth Hurun India Rich List 2022. The report found 1,103 Indians with a networth of Rs 1,000 crore each - an increase of 62 per cent over five years. There are 221 billionaires (Rs 100 crore networth) in India on the 2022 list - down 16 compared with last year, while 13 people born in the 1990s made it to the list, all self-made.

Centre issues alert to states over Tomato Flu in children

Centre issues alert to states over Tomato Flu in children

Rediff.com24 Aug 2022

Centre has sent an advisory to states on HFMD (Hand Foot and Mouth Disease), commonly known as Tomato Flu, stating that it's a self-limiting illness targeting mostly young children aged 1-10 years and immune-compromised adults and no specific drug exists to treat it.

Sitharaman walks the tech talk with AI, data governance, digilocker in Budget

Sitharaman walks the tech talk with AI, data governance, digilocker in Budget

Rediff.com1 Feb 2023

The Union Budget on Wednesday outlined several initiatives to drive India's technology agenda and boost digital infrastructure, including new centres of excellence for artificial intelligence, National Data Governance Policy, and Entity DigiLocker.

What India needs to do to avert China-like Covid surge

What India needs to do to avert China-like Covid surge

Rediff.com28 Dec 2022

"Provide enough infrastructure and money to carry out surveillance and set up a robust routine surveillance machinery for the country to monitor any and every infectious disease'

How to get an IIT degree without clearing JEE

How to get an IIT degree without clearing JEE

Rediff.com3 Aug 2022

The last date to apply for the September 2022 term of the programme is August 19, 2022.

Pfizer jab produces less antibodies against Delta variant: Study

Pfizer jab produces less antibodies against Delta variant: Study

Rediff.com4 Jun 2021

The study also shows that levels of these antibodies that are able to recognise and fight the virus are lower with increasing age, and that levels decline over time, providing additional evidence in support of plans to deliver a booster dose to vulnerable people.

'I cried an ocean of tears when I had no work'

'I cried an ocean of tears when I had no work'

Rediff.com8 Dec 2022

'Actors like me heave a sigh of relief if we get work.'

Wipro tops list of 300-plus stocks to hit 52-week lows

Wipro tops list of 300-plus stocks to hit 52-week lows

Rediff.com14 May 2022

Analysts believe that investors should look at stocks that hit 52-week lows only if they have a dividend paying track record, are debt-free and have sound fundamentals.

Covaxin gets nod for phase 2, 3 clinical trials on 2-18 year-olds

Covaxin gets nod for phase 2, 3 clinical trials on 2-18 year-olds

Rediff.com12 May 2021

The trial will take place in 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur.

Pharma funds: 'Enter with a horizon of 5-7 years or more'

Pharma funds: 'Enter with a horizon of 5-7 years or more'

Rediff.com14 Mar 2023

In contrast with their strong performance in 2020 and 2021, pharmaceutical and healthcare funds experienced a decline in 2022, with returns plummeting by an average 9.8 per cent. This trend has continued in the current year, with year-to-date return remaining in the negative (-4.9 per cent). In the past three months, pharma funds have been hit hard, experiencing a 7.9 per cent decline.

Covaxin 50% effective against symptomatic Covid: Lancet

Covaxin 50% effective against symptomatic Covid: Lancet

Rediff.com24 Nov 2021

Results of an interim study recently published in The Lancet showed that two doses of Covaxin, also known as BBV152, had 77.8 per cent efficacy against symptomatic disease and present no serious safety concerns.

Vandana Maurya's story: From a biotech researcher to a social worker

Vandana Maurya's story: From a biotech researcher to a social worker

Rediff.com15 Jun 2015

Vandana has been attempting to bring in radical changes in the unhealthy food habits amongst the tribals.

5 DRDO labs where everyone is under 35!

5 DRDO labs where everyone is under 35!

Rediff.com3 Jan 2020

'Each lab is working on a key advanced technology of importance to the development of futuristic defence.'

Covaxin has shown good response in kids: Govt panel doc

Covaxin has shown good response in kids: Govt panel doc

Rediff.com27 Dec 2021

He explained, "Children between the age of 12 and 18 years, particularly those in the age group of 15 to 18 years, are very much like adults. Our research within the country also says that almost two-thirds of the deaths below 18 years which occurred due to COVID in India are within this age group. So, this decision was mainly taken to protect the adolescents."

Who stops us from correcting 'distortions' in history, asks Shah

Who stops us from correcting 'distortions' in history, asks Shah

Rediff.com25 Nov 2022

'If we do this, we will see that the true history of India will be established and the lies will end spontaneously'

Shah appeals for peace in Manipur, to 'visit soon'

Shah appeals for peace in Manipur, to 'visit soon'

Rediff.com26 May 2023

Union Home Minister Amit Shah on Thursday appealed to the people of Manipur to maintain peace and promised that justice will be ensured to all sections of the society.

Why Mumbaikars Are Wheezing And Coughing

Why Mumbaikars Are Wheezing And Coughing

Rediff.com29 Mar 2023

La Nina, construction worsen air quality; spike in respiratory ailments.

COVID vaccines disease-modifying, don't prevent infection: ICMR

COVID vaccines disease-modifying, don't prevent infection: ICMR

Rediff.com30 Dec 2021

All COVID vaccines do not prevent infection and are primarily disease-modifying, said Dr Balram Bhargava, director general, Indian Council of Medical Research on Thursday.

DGCI approves Covaxin for phase 2/3 trials on children

DGCI approves Covaxin for phase 2/3 trials on children

Rediff.com13 May 2021

India's apex drug regulator has granted permission for conducting the phase II/III clinical trial of Bharat Biotech's Covaxin COVID-19 vaccine in the age group of 2 to 18 years, the Union Health Ministry said on Thursday.

Govt invites applications for chief economic adviser post

Govt invites applications for chief economic adviser post

Rediff.com26 Oct 2021

The government has invited applications for the post of chief economic adviser (CEA) to replace K V Subramanian, who will complete his three-year tenure next month. Subramanian was appointed as CEA on December 7, 2018, while he assumed charge on December 24 in the same year. As per the public notice dated October 24, 2021 issued by Department of Economic Affairs, the Ministry of Finance, officer of central, state governments, RBI and public sector banks holding analogous post on regular basis in parent cadres or department are eligible to apply for the post.

Live Your Best Life AFTER Menopause

Live Your Best Life AFTER Menopause

Rediff.com30 Jul 2022

The inclination for sex also increases because the messiness of periods, the need for contraception and the fear of pregnancy are over, the nest is empty and her partner retired, with all the time in the world at their disposal to indulge in such activities, which makes them enjoy it all the more!

Lancet Study finds Russian vaccine safe, effective

Lancet Study finds Russian vaccine safe, effective

Rediff.com4 Sep 2020

Results from early-phase non-randomised vaccine trials in a total of 76 people show that two formulations of the vaccine have a good safety profile detected over 42 days, and induce antibody responses in all participants within 21 days.

Primary market revival is still some time away, say analysts

Primary market revival is still some time away, say analysts

Rediff.com8 Sep 2022

It has been a slow 2022 thus far for the primary markets. In the last 8 months, only 16 companies have raised Rs 40,311 crore via the initial public offer (IPO) route, data from PRIME Database suggests. In comparison, 63 companies had raised a cumulative Rs 1.18 trillion via the IPO route in 2021. A large part of the funds raised in 2022 were on account of the two IPOs - Life Insurance Corporation of India (LIC) and logistics firm Delhivery - that raised a total of over Rs 26,000 crore between themselves.

A, B blood groups, Rh+ people more prone to Covid: Study

A, B blood groups, Rh+ people more prone to Covid: Study

Rediff.com30 Nov 2021

People having blood group of A, B and those with Rh factor positive are "more susceptible to COVID-19 infection" compared to those having O or AB group and Rh negative, according to a new study conducted by doctors at a Delhi hospital.

'Had Shashi won, Congress would have gained'

'Had Shashi won, Congress would have gained'

Rediff.com22 Oct 2022

'I would like to see Kharge include Shashi in the Congress Working Committee.' 'The other alternative is that the Congress will marginalise him.'

Bio E gets nod for kids' phase 2, 3 Covid vax trial

Bio E gets nod for kids' phase 2, 3 Covid vax trial

Rediff.com3 Sep 2021

Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology (DBT) said on Friday.

Adani role in defence sector comes as fresh ammo for Oppn

Adani role in defence sector comes as fresh ammo for Oppn

Rediff.com15 Mar 2023

Several Opposition leaders, including former Congress chief Rahul Gandhi, on Wednesday attacked the government over a media report claiming that a key Adani group investor is also co-owner with the conglomerate in a defence firm.

Why Investors Must Build Diversified Portfolio

Why Investors Must Build Diversified Portfolio

Rediff.com23 Jan 2023

Rebalance the portfolio at least once a year to ensure it remains in sync with the target asset allocation.

Two-wheeler stocks may enter the fast lane riding on recovery hopes

Two-wheeler stocks may enter the fast lane riding on recovery hopes

Rediff.com2 May 2022

The two-wheeler sector has been underperforming its peers on the volumes front for over five quarters now. Even in the March quarter, Bajaj Auto and Hero MotoCorp posted a 17-24 per cent YoY decline in volumes, the sharpest in the listed auto universe. The ongoing impact of frequent price hikes, all-time high fuel prices, and muted rural sentiment has led to the lacklustre showing by two-wheeler makers. What has aggravated the situation for two-wheeler companies, which get almost all their sales from the internal combustion engine or ICE-based units, is the traction for electric two-wheelers (EV).

BEWARE! Fraud Journals On The Rise

BEWARE! Fraud Journals On The Rise

Rediff.com27 Nov 2021

Cloned journals have become more rampant in the post-pandemic world.

How monkeys were tracked for Covaxin trial

How monkeys were tracked for Covaxin trial

Rediff.com14 Nov 2021

The Rhesus macaque monkeys, used worldwide in medical research, are believed to be the best non-human primates for such studies.

Fix age and wage issues before raising H-1B cap, argues visa's critic

Fix age and wage issues before raising H-1B cap, argues visa's critic

Rediff.com10 Sep 2013

Norman Matloff, professor of computer science at the University of California, Davis, believes that the US has enough highly skilled engineers and raising the cap on H-1B would hamper the wages of senior workers already in the industry.

Isro executes controlled re-entry of decommissioned satellite

Isro executes controlled re-entry of decommissioned satellite

Rediff.com8 Mar 2023

The Indian Space Research Organisation said it successfully carried out an "extremely challenging" controlled re-entry experiment of the decommissioned orbiting Megha-Tropiques-1 (MT-1) satellite.

GACs to have wider scope, will hear all types of grievance appeals

GACs to have wider scope, will hear all types of grievance appeals

Rediff.com9 Jan 2023

MeitY had stated there was a need to set up GACs as grievance officers hired by the platforms often did not address issues satisfactorily.

'Science is a team sport'

'Science is a team sport'

Rediff.com21 Nov 2022

'Working in collaboration is beneficial and more rewarding in the long run.' 'Competition may bring personal glory, but is very short lasting.' 'Work with people who are interested in working with you instead of competing with you.'